Company intelligence / Profile preview

Exigent Capital Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Exigent Capital Group is a boutique merchant bank and investment holding company. It focuses on private equity, credit financing, real estate, and GP stake investing across various sectors, including healthcare. The firm provides family office services, investment products, and strategic advisory. Through Exigent Research, it operates a community oncology research network involved in clinical trials, such as the BEGIN Study with BostonGene. Exigent also plans significant investments in Bahrain focusing on healthcare, food security, energy, water, and education.

Industry: Investors

Partnerships

BostonGeneQuality Cancer Care Alliance (QCCA)National Cancer Care Alliance (NCCA)

Beyond the preview

Go deeper on Exigent Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exigent Capital Group.

Explore the full profile